Jump to content


Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Pulmonary Fibrosis In Systemic Sclerosis And Dermatomyositis Demonstrates Marked Improvement After Administration Of Mycophenolate Mofetil


  • Please log in to reply
No replies to this topic

#1 Guest_Jude the Grouch_*

Guest_Jude the Grouch_*
  • Guests

Posted 30 August 2007 - 08:44 AM

Pulmonary Fibrosis In Systemic Sclerosis (SSc) And Dermatomyositis (DM) Demonstrates Marked Improvement After Administration Of Mycophenolate Mofetil (MMF/Cellcept). MMF's immunomodulatory and inhibitory effects on fibroblasts and other non-immune cells and a well established low side effect profile with high tolerance make MMF a potential alternative to cyclophosphamide in the treatment of SSc or DM related interstitial lung disease. L. A. Saketkoo THU0315 EULAR 2007. (Also see: Pulmonary Fibrosis and Dermatomyositis)